Invasive pulmonary aspergillosis (IPA) is a life-threatening infectious complication in neutropenic patients after high-dose chemotherapy or hematopoietic stem cell transplantation. Its diagnosis is mainly based on clinical symptoms, and radiological signs on thoracic CT scan. The value of bronchoscopy is controversial. We analyzed the diagnostic yield of bronchoscopy in 23 consecutive patients with histologically proven invasive pulmonary aspergillosis. In seven patients (30%) bronchoscopically obtained specimens were diagnostic for pulmonary fungal infection. Typical hyphae were detected by cytology in six patients and fungal cultures were positive in four cases. Patients with a positive bronchoscopic result presented more often with multiple changes on thoracic CT scan (71%; 5/7), but had received a lower median cumulative dose of amphotericine B (300 mg; 168-3010 mg) compared to patients with non-diagnostic bronchoscopy (25% multiple lesions (4/16); amphotericine dose 1100 mg, 260-2860 mg). The diagnostic yield of bronchoscopy was not associated with clinical symptoms or duration of neutropenia. Bronchoscopy allows the diagnosis of IPA in about one third of patients. Fungal cultures and cytological examination of intrabronchial specimens obtained during bronchoscopy have a high specificity, but its sensitivity is low. It is advisable to perform diagnostic bronchoscopy before starting antifungal therapy. Better diagnostic tools are urgently needed.
cated recently. However, about 20% of patients who underwent surgery did not have IPA. 4, 5 IPA has to be considered if antibiotic resistant fever develops in neutropenic patients, with infiltrates on the chest X-ray. Typical thoracic computed tomography (CT) changes include the halo-sign, air crescent sign, or cavitary lesions. 6 IPA can also be found in lesions presenting as localized infiltrates and consolidations on CT scan in the absence of these typical findings. 5 CT scan has a diagnostic sensitivity of 72-82% in patients with histologically proven IPA. 4, 5 Bronchoscopy with bronchoalveolar lavage is an established method for the diagnosis of infectious pulmonary complications in neutropenic patients. 7 Respiratory tract cultures for IPA are regarded as highly specific, but rather low in sensitivity. 7, 8 In this study, we report the diagnostic yield of bronchoscopy for IPA in neutropenic patients with histologically proven invasive fungal infection following high-dose chemotherapy or SCT. Clinical and radiological data are compared between patient groups with a positive and a negative bronchoscopic result, respectively.
Patients and methods
Over a 10-year period, 23 patients who underwent diagnostic bronchoscopy with bronchoalveolar lavage had histologically proven invasive pulmonary fungal infection: 13 male and 10 female patients with a median age of 46 years (8-68 years). 18 patients had received high-dose chemotherapy. Indications were acute lymphoblastic leukemia (ALL, n = 4), acute myeloid leukemia (AML, n = 8), chronic myelomonocytic leukemia (CMML, n = 1), nonHodgkin's lymphoma (NHL, n = 3), testicular cancer (n = 1), and colorectal cancer with bone marrow aplasia (n = 1). Two patients underwent hematopoietic stem cell transplantation for chronic myeloid leukemia (CML; allogeneic PBSCT), and NHL (autologous BMT), respectively. Three patients were treated with anti-lymphocyte globulin (ALG) for severe aplastic anemia (AA).
Diagnostic bronchoscopy was performed using sterilized bronchoscopes under local anesthesia according to the guidelines of the European Respiratory Society. 9 If the platelet count was below 20 × 10 9 /l platelet pools were given. There were no complications due to the bronchoscopic procedure. Intrabronchial specimens were obtained by instil- lation of pyrogen-free sterile 0.9% NaCl solution into the segment with the most prominent radiological infiltrate. Bronchial lavages were performed with at least 10 ml NaCl and bronchoalveolar lavage with 3 × 50 ml. The fluid recovered was examined for fungal growth on Sabouraud culture medium. Cytological analysis of BAL was performed with hematoxylin-eosin and Grocott's staining. Diagnostic and therapeutic lung resection was performed if neutropenic patients presented with antibiotic-resistant fever and localized infiltrates on the CT scan irrespective of whether fungi were cultured from BAL. Data were collected based on patients' symptoms, type of radiological changes, duration of neutropenia (neutrophil counts below 0.5 × 10 9 /l), duration and cumulative dosage of antifungal therapy, and histological findings.
Statistical analysis was performed using Fisher's exact test and Mann-Whitney's U-test with a level of significance at P Ͻ 0.05.
Results
Fungal infection was diagnosed by bronchoscopy in seven of 23 patients with histologically proven IPA (30%) as shown in Table 1 . Cytological examination was positive in six, and fungal cultures were positive in four cases.
Twenty patients (87%) presented with fever of a median duration of 10 days (3-32 days). Further clinical symptoms were thoracic pain (8 patients), cough (4 patients), and dyspnea (4 patients). Two patients were mechanically ventilated prior to bronchoscopy because of respiratory failure. One patient developed hemoptysis after CT-guided transthoracic lung biopsy.
In all patients chest X-ray or thoracic CT scan showed new changes: in 14 patients localized and in nine patients multiple lesions. Most of the patients presented with infiltrates (n = 16), either localized (n = 9) or multiple (n = 7). In the other seven patients nodular (n = 5) or cavitary (n = 2) lesions were present.
All patients were neutropenic prior to bronchoscopy with a median duration of 20 days (range 4-133 days).
Twenty patients (87%) received amphotericin B (AmB) with a median cumulative dose of 1000 mg (range 168-3010 mg) over a median of 14 days (range 4-78 days). Two patients were receiving AmB in combination with voriconazole and flucytosine, respectively. In the three patients not receiving antifungal therapy, BAL was negative for fungal infection despite histologically proven IPA.
IPA was confirmed by histology at a median of 5 days after bronchoscopy (range 0-80 days). In 16 patients IPA was proven by surgery (13 lobectomy, two wedge resection and one open lung biopsy), and one patient underwent CTguided transthoracic lung biopsy. Histological specimen of the lung were obtained at a median of 2 days (range 0-28 days) after bronchoscopic intervention. In six patients IPA was confirmed by autopsy performed at a median of 17 days after bronchoscopy (Table 1) .
In the group with positive bronchoscopic results five of seven patients (71%) had multiple changes on thoracic CT scan as compared to four of 16 patients (25%) with negative bronchoscopic results. Bronchoscopy was positive in only Table 2 Distribution of lesions on thoracic CT scan according to bronchoscopic diagnosis of fungal infection in 23 patients with histologically proven IPA
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Bronchoscopy positive 14% (n = 2) 56% (n = 5) Bronchoscopy negative 86% (n = 12) 44% (n = 4) 14% of patients with localized infiltrates, but in 56% of patients with multiple lesions (P Ͻ 0.05) ( Table 2) . Patients with positive bronchoscopic results had received a lower cumulative dose of amphotericin B prior to bronchoscopy than patients with negative bronchoscopy (300 vs 1100 mg; not significant) There were no differences between the two groups concerning duration of fever and neutropenia, or presence of respiratory symptoms (Table 3) .
Discussion
This study confirms the limited value of bronchoscopy for the diagnosis of IPA. Bronchoscopically obtained specimens were positive in seven of 23 patients with histologically proven invasive fungal infection (30%). Cytology revealed typical hyphae in six cases, and fungal culture was positive in four cases. In 16 cases (69%) IPA was confirmed by lung resection. BAL was often negative despite extensive fungal infection histologically documented in lung tissue. All cases showed angioinvasiveness of fungi and lung infarction. BAL fluid is recovered by bronchoscopy from the bronchoalveolar compartment which might explain the low diagnostic yield of BAL, even if BAL is performed in the lung segment with infarction. We did not find any association between positive bronchoscopic result and clinical parameters, such as presence of respiratory symptoms, duration of antibiotic resistant fever, neutropenia, and antifungal therapy, respectively. The lower time span between bronchoscopy and histological confirmation of IPA in the group of non-diagnostic BAL is related to the high percentage of patients undergoing surgical resection in this group.
Patients with a positive bronchoscopic result had received a lower cumulative dose of AmB prior to bronchoscopy compared to patients with a negative bronchoscopy. Although not significantly different in this study, the low diagnostic yield of bronchoscopy for the diagnosis of IPA might therefore be influenced by the intensity of previous antifungal treatment. The difference between cytology and fungal culture may be related to the fact, that in vitro fungal growth is inhibited by previous treatment with AmB, whereas pulmonary fungal infection persists, and typical hyphae are still present at cytology. In neutropenic patients with antibiotic-resistant fever and suspected fungal infection, diagnostic bronchoscopy with BAL should be performed before antifungal treatment is started. Pulmonary surveillance by bronchoscopy with BAL during neutropenia might be a beneficial option. 10 Patients with a positive bronchoscopy had more often advanced stages of invasive pulmonary fungal infection as indicated by multiple pulmonary changes on thoracic CT scan and a high rate of histological confirmation of IPA by autopsy. This implies that detection of pulmonary fungal infection by cytology or culture might be a negative predictor for overall outcome.
Previous studies analyzing the diagnostic value of bronchoscopy in IPA showed a high specificity of close to 100%. However, published values for sensitivity vary considerably (0-89%). In histologically proven IPA, the overall diagnostic sensitivity of bronchoscopy is 43% (Table 4) . As in our study, cytological detection of hyphae appears superior to fungal culture. 11 One study compared bronchial washings and BAL in a small group which was too small for definite conclusions. 12 Over recent years new tests based on antigen-detection of Aspergillus spp, 13 and tests for detection of aspergillusantigens or DNA in BAL have been developed.
14 Various studies evaluating different commercial tests show highly variable results and their value in the diagnosis of IPA is debatable. None of these tests has been introduced into routine clinical practice to date. PCR for Aspergillus in BAL is a relatively new technique. Only a few studies with different aspergillus-related lung diseases have been published currently. Its diagnostic value in IPA needs to be further assessed (Table 5) .
In summary, commonly used cytology and culture methods of bronchoscopically obtained specimens are of limited value in the diagnosis of IPA because of a low sensitivity. Precise diagnostic methods are urgently needed. When IPA is suspected bronchoscopy should be performed before establishing antifungal therapy. However, if the BAL result is also negative antifungal therapy should be given and therapeutic lung resection should be discussed.
